Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus

Abstract Background The purpose of this study was to evaluate and compare the effects on laboratory parameters among monotherapy with five DPP-4 inhibitors in patients with type 2 diabetes mellitus (DM). Methods We identified cohorts of new sitagliptin users (n = 879), vildagliptin users (n = 253),...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Yayoi Nishida, Yasuo Takahashi, Kotoe Tezuka, Hayato Akimoto, Tomohiro Nakayama, Satoshi Asai
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMC 2020-04-01
Serie:BMC Pharmacology and Toxicology
Soggetti:
Diabetes mellitus
Dipeptidyl-peptidase 4 inhibitor
Sitagliptin
Vildagliptin
Teneligliptin
Alogliptin
Accesso online:http://link.springer.com/article/10.1186/s40360-020-00407-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi